CD47 and non-Hodgkin lymphoma: Chao and colleagues reported that CD47 was overexpressed on samples derived from patients with various NHL subtypes (DLBCL,B-CLL, MCL, FL, MZL, pre-B ALL) and high CD47 expression correlated with poor clinical prognosis in NHL patients (173, 175).